Sage Journals: Discover world-class research

Open access

Review article

First published 2020

Targeting non-small cell lung cancer: driver mutation beyond epidermal growth factor mutation and anaplastic lymphoma kinase fusion

Quincy S. Chu

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2024-11

Case report: targeted therapy of malignant pleural mesothelioma with anaplastic lymphoma kinase receptor tyrosine kinase gene fusion mutation by crizotinib

Yufeng Wu, Yuhua Zhao, Limeng Yu [...]

Journal of International Medical Research

Retricted access

Case report

First published 2020-9

Life-threatening hypertriglyceridemia-induced pancreatitis related to alectinib successfully treated by plasmapheresis: A review of the literature on metabolic toxicities associated with anaplastic lymphoma kinase inhibitors

Arundati Rao, Aswanth Reddy, Corey Dinunno [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2022-4

Brigatinib is a cost-effective treatment in first-line anaplastic lymphoma kinase mutation-positive (ALK + ) advanced non-small cell lung cancer (NSCLC) with brain metastases

Jacopo Giuliani

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2023

Identification of ALK Mutation in Neuroblastoma on the Point of Molecular Heterogeneity

Tekincan Çağrı Aktaş, Deniz Kızmazoğlu, Safiye Aktaş [...]

Technology in Cancer Research & Treatment

Open access

Case report

First published 2019

Genetic and immunohistochemical analyses of ciliated muconodular papillary tumors of the lung: A report of five cases

Jumpei Kashima, Tsunekazu Hishima, Akiko Tonooka [...]

Sage Open Medical Case Reports

Open access

Review article

First published 2017-12

Ceritinib: A primer for pharmacists

Trang H Au, Courtney C Cavalieri, David D Stenehjem

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2019-4

Crizotinib-induced erosive esophagitis in a pediatric patient with neuroblastoma

Nicole Lubcke, Kevin Van Camp

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2017-7

High expression of SLC34A2 is a favorable prognostic marker in lung adenocarcinoma patients

Zhaoxuan Zhang, Shan Ye, Min Zhang [...]

Tumor Biology

Free access

Review article

First published 2016-5

Overcoming resistance to first/second generation epidermal growth factor receptor tyrosine kinase inhibitors and ALK inhibitors in oncogene-addicted advanced non-small cell lung cancer

Ourania Romanidou, Lorenza Landi, Federico Cappuzzo [...]

Therapeutic Advances in Medical Oncology

Search results